Officer Files Form 144 to Sell $570K in Shares, Continuing Recent Sales Pattern
VMD sits 46% above its 52-week low of $5.93 on elevated volume (3.0× avg).
Summary
An officer of Viemed Healthcare, Inc. has filed a Form 144 indicating an intent to sell 65,000 common shares, valued at approximately $570,115, following recent sales by the same insider.
Key Events · Ownership and Investor Activity · VMD
-
Officer Files Intent to Sell Shares
MOORE FASTER LLC, identified as an officer, filed a Form 144 to sell 65,000 common shares.
-
Significant Proposed Sale Value
The proposed sale has an approximate market value of $570,115.
-
Follows Recent Insider Sales
This filing continues a pattern of sales by the same insider, who previously sold 71,802 shares for $667,765.25 on March 18th and 19th.
-
Shares Acquired Through Merger
The shares were acquired on December 22, 2017, through a merger/acquisition for services rendered.
Analysis · VMD · Industrial Applications And Services
This Form 144 indicates a significant intent to sell by an officer, MOORE FASTER LLC, representing approximately $570,115 in common shares. This filing continues a pattern of share disposition by the same insider, following two previous Form 144s on March 18th and 19th. While the company recently authorized a share repurchase program, these repeated insider sales could be perceived negatively by investors, suggesting a need for liquidity or a shift in sentiment from the selling officer.
How filings like this one have moved
In the 30 days to Oct 1, 2026, 30.2% of the 1644 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.49%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, VMD was trading at $8.63 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $336.2M. The 52-week trading range was $5.93 to $10.06. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.